Marathon Asset Management Ltd Sells 25,247 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Marathon Asset Management Ltd reduced its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 9.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 236,745 shares of the company's stock after selling 25,247 shares during the period. Marathon Asset Management Ltd owned approximately 0.19% of Henry Schein worth $16,215,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Invesco Ltd. increased its holdings in Henry Schein by 0.4% in the 4th quarter. Invesco Ltd. now owns 4,963,409 shares of the company's stock valued at $343,468,000 after acquiring an additional 17,552 shares during the last quarter. FMR LLC increased its holdings in Henry Schein by 6.6% in the 4th quarter. FMR LLC now owns 3,498,033 shares of the company's stock valued at $242,064,000 after acquiring an additional 217,143 shares during the last quarter. Geode Capital Management LLC increased its holdings in Henry Schein by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company's stock valued at $218,762,000 after acquiring an additional 14,876 shares during the last quarter. Palestra Capital Management LLC bought a new stake in shares of Henry Schein in the 4th quarter worth about $182,988,000. Finally, Fiduciary Management Inc. WI increased its holdings in shares of Henry Schein by 7.2% in the 4th quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company's stock worth $172,193,000 after buying an additional 167,990 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

HSIC has been the topic of a number of research reports. Barrington Research reduced their target price on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a report on Tuesday, May 6th. Wells Fargo & Company reduced their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Wall Street Zen downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Finally, Piper Sandler reduced their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $79.30.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC opened at $73.27 on Friday. The company has a market capitalization of $8.92 billion, a price-to-earnings ratio of 22.90, a PEG ratio of 2.36 and a beta of 0.86. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The firm's 50-day moving average is $69.76 and its 200 day moving average is $71.23. The company has a current ratio of 1.38, a quick ratio of 0.75 and a debt-to-equity ratio of 0.50.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.11 by $0.04. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The firm's revenue was down .1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.10 EPS. Research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.